TSX.V: MAI
Near term gold production company focused in Mexico
$50 million Merger with Minera Alamos Inc. April 13, 2018
RainCity Capital Partners is a Vancouver based investment firm with a team of seasoned professionals. We offer a full spectrum of capital market services and expertise for companies that have an opportunity to thrive in dynamic sectors.
As a boutique firm we can react quickly to market forces, industry changes, regulatory adaptations, and sector pivots. With our network of influential partners, a proven track record and a willingness to understand your business, we trust you’ll find our ideas insightful, our plans innovative and our results exceptional.
OUR SERVICES
FUNDING
Within our network you’ll be able to access investment banks, institutional and high net-worth investors in the United States, Canada, and Europe. Having raised over $150 million for publicly traded and private companies you’ll gain access to the depth of our experience and services. It’s with our hands-on approach that we can provide the capital required to accelerate your business.
MERGERS & ACQUISITIONS
We are accomplished in taking private ventures public through Initial Public Offerings and Reverse Take Over transactions on every Canadian exchange as well as OTCQB and NASDAQ. We have executed and advised on numerous M&A transactions in a wide range of industries and sectors.
STRATEGIC PLANNING
Our ability to understand and manage the evolving competitive landscape will help steer you on the path to success. From assisting in finding human capital, corporate development, go public transactions, valued added opportunities and exit strategies, our collective efforts are the steps you need to advance your company.
SECTOR EXPERIENCE
$
0
Raised and Invested
PORTFOLIO
TSX: EFR
NYSE: UUUU
Uranium exploration company focused in the United States
Acquired by TSX listed Energy Fuels. June 30, 2009
NASDAQ: INM
TSX: IN
Biopharmaceutical company specializing in cannabinoid-based therapeutics
Nasdaq up-listing April 2021
TSX up-listing March 22, 2018
CSE: CHOO
OTCQB: CHOOF
Canadian Cannabis Retailer
$27 million investment from Aurora Cannabis Inc.
TRYP: CSE
Tryptamine Therapeutics Limited is a clinical-stage biotechnology company
December, 2020
TSX.V: TIGR
Advanced stage, multi-million ounce gold development company in Colombia
$16.5m RTO
December, 2025
OUR TEAM
Chris Bogart,
Managing Partner
Mr. Bogart has 22 years professional experience in senior management positions with public and private companies, providing expertise in capital markets, strategic planning, corporate finance, mergers and acquisitions and regulatory compliance. His broad industry experience includes; biotechnology, healthcare, technology, communications, agriculture, and he has been involved directly in M&A and equity financings with aggregate values in excess of $150M for both public and private companies including complex equity financing transactions in the United States, Canada and Europe. Mr. Bogart was a Co-Founder of TSX listed InMed Pharmaceuticals (TSX: IN), previously as their CEO and VP of Corporate Strategy; and a Co-Founder of Magnum Uranium which was acquired by TSX listed Energy Fuels Inc.